EPHX2 and hydrops fetalis: Although sEH inhibition did not change HF-diet–increased plasma cholesterol level and insulin resistance, the elevated blood pressure, hepatic steatosis, and liver content of triglycerides and cholesterol were significantly attenuated with sEHI treatment (Fig. 4E).